Quick Answer
Health In Tech, Inc. reported Total Revenue of $33.33 million for fiscal year 2025.
Health In Tech, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $33.33M +71.0% |
$19.49M +1.8% |
$19.15M | — |
| Net Income | $1.28M +90.7% |
$670.5K | — | — |
| Diluted EPS | $0.02 +100.0% |
$0.01 | — | — |
| Total Assets | $23.09M +46.4% |
$15.77M +37.1% |
$11.50M | — |
| Cash and Equivalents | $7.67M -2.3% |
$7.85M +224.8% |
$2.42M | — |
| Stockholders Equity | $17.11M +29.9% |
$13.17M +116.1% |
$6.09M +329.6% |
$1.42M |
| R&D Expense | $1.57M -44.2% |
$2.81M +40.4% |
$2.00M | — |
| Gross Profit | $20.94M +35.6% |
$15.44M -8.4% |
$16.85M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $8.49M | +90.4% | -8.8% |
| Net Income | September 30, 2025 | $452.2K | +20.2% | -28.3% |
| Diluted EPS | September 30, 2025 | $0.01 | +0.0% | +0.0% |
| Total Assets | September 30, 2025 | $22.76M | — | +2.6% |
| Cash and Equivalents | September 30, 2025 | $8.02M | — | -1.4% |
| Stockholders Equity | September 30, 2025 | $17.16M | +148.4% | +4.5% |
| R&D Expense | September 30, 2025 | $235.8K | -67.2% | -59.5% |
| Gross Profit | September 30, 2025 | $5.14M | +47.8% | -18.5% |
- Health In Tech, Inc. reported Total Revenue of $33.33 million for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +71.0% in Total Revenue compared to the prior fiscal year.
- Health In Tech, Inc. reported Net Income of $1.28 million for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +90.7% in Net Income compared to the prior fiscal year.
- Health In Tech, Inc. reported Diluted EPS of $0.02 per share for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +100.0% in Diluted EPS compared to the prior fiscal year.
- Health In Tech, Inc. reported Total Assets of $23.09 million for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +46.4% in Total Assets compared to the prior fiscal year.
- Health In Tech, Inc. reported Cash and Equivalents of $7.67 million for fiscal year 2025.
- Health In Tech, Inc. showed a decrease of -2.3% in Cash and Equivalents compared to the prior fiscal year.
- Health In Tech, Inc. reported Stockholders Equity of $17.11 million for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +29.9% in Stockholders Equity compared to the prior fiscal year.
- Health In Tech, Inc. reported R&D Expense of $1.57 million for fiscal year 2025.
- Health In Tech, Inc. showed a decrease of -44.2% in R&D Expense compared to the prior fiscal year.
- Health In Tech, Inc. reported Gross Profit of $20.94 million for fiscal year 2025.
- Health In Tech, Inc. showed an increase of +35.6% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: